NRC Health: 3 Key Takeaways for Long-Term Investors

NRC Health reported Q3 2026 results showing 11% growth in total recurring contract value to $151.9M while maintaining 27% adjusted EBITDA margins despite heavy implementation spending. The company identified three key opportunities: contract value growth outpacing revenue as system implementations scale, 70% of customers using only one product offering massive expansion potential, and a 60% increase in sales pipeline amid competitor consolidation. Management expects margin expansion in H2 2026 as revenue reflects recent TRCV growth.